CA2719162C - Methods of treating acne - Google Patents

Methods of treating acne Download PDF

Info

Publication number
CA2719162C
CA2719162C CA2719162A CA2719162A CA2719162C CA 2719162 C CA2719162 C CA 2719162C CA 2719162 A CA2719162 A CA 2719162A CA 2719162 A CA2719162 A CA 2719162A CA 2719162 C CA2719162 C CA 2719162C
Authority
CA
Canada
Prior art keywords
methods
treating acne
human
acne
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2719162A
Other languages
English (en)
French (fr)
Other versions
CA2719162A1 (en
Inventor
Robert A. Ashley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Pharma SA
Original Assignee
Galderma Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2719162(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Pharma SA filed Critical Galderma Pharma SA
Publication of CA2719162A1 publication Critical patent/CA2719162A1/en
Application granted granted Critical
Publication of CA2719162C publication Critical patent/CA2719162C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2719162A 2001-04-05 2002-04-05 Methods of treating acne Expired - Lifetime CA2719162C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05
US60/281,916 2001-04-05
CA2440472A CA2440472C (en) 2001-04-05 2002-04-05 Methods of treating acne

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2440472A Division CA2440472C (en) 2001-04-05 2002-04-05 Methods of treating acne

Publications (2)

Publication Number Publication Date
CA2719162A1 CA2719162A1 (en) 2002-10-17
CA2719162C true CA2719162C (en) 2014-12-23

Family

ID=23079310

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2719162A Expired - Lifetime CA2719162C (en) 2001-04-05 2002-04-05 Methods of treating acne
CA2440472A Expired - Lifetime CA2440472C (en) 2001-04-05 2002-04-05 Methods of treating acne

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2440472A Expired - Lifetime CA2440472C (en) 2001-04-05 2002-04-05 Methods of treating acne

Country Status (12)

Country Link
EP (4) EP1383508B1 (https=)
JP (3) JP2004536046A (https=)
KR (1) KR100926326B1 (https=)
AT (1) ATE330615T1 (https=)
AU (1) AU2002303250B2 (https=)
CA (2) CA2719162C (https=)
DE (1) DE60212613T2 (https=)
DK (1) DK1383508T3 (https=)
ES (1) ES2266499T3 (https=)
NZ (1) NZ528197A (https=)
PT (1) PT1383508E (https=)
WO (1) WO2002080932A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551708T3 (es) * 2002-01-08 2015-11-23 Paratek Pharmaceuticals, Inc. Compuestos de 4-desdimetilamino tetraciclina
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
WO2004091483A2 (en) 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
AU2004261143B2 (en) 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
KR20130137696A (ko) * 2007-03-23 2013-12-17 몰레큘러 리서치 센터, 인크. 테트라사이클린류를 함유하는 항염증성 조성물 및 이의 치료 용도
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
KR20140146095A (ko) * 2012-04-19 2014-12-24 갈데르마 소시에떼아노님 여드름의 치료 방법
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
CN111343991A (zh) * 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
WO2020142350A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278457D1 (en) * 1981-08-27 1988-06-16 Soft Sheen Products Inc Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
WO1992003133A1 (en) * 1990-08-16 1992-03-05 Bloom, Leonard Topical treatment of blepharitis
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
CA2343038A1 (en) * 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
DE69932846T2 (de) * 1998-11-18 2007-03-15 Collagenex Pharmaceuticals, Inc. Neue 4-dedimethylaminotetracyclinderivate
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Also Published As

Publication number Publication date
EP1716856A2 (en) 2006-11-02
EP1712236A2 (en) 2006-10-18
EP1716856A3 (en) 2009-02-18
CA2440472A1 (en) 2002-10-17
DE60212613D1 (de) 2006-08-03
CA2719162A1 (en) 2002-10-17
AU2002303250B2 (en) 2006-05-25
PT1383508E (pt) 2006-11-30
DK1383508T3 (da) 2006-12-27
KR100926326B1 (ko) 2009-11-12
EP1712236A3 (en) 2008-05-28
JP2004536046A (ja) 2004-12-02
KR20040007488A (ko) 2004-01-24
JP2010053155A (ja) 2010-03-11
DE60212613T2 (de) 2007-05-24
EP1383508A1 (en) 2004-01-28
CA2440472C (en) 2011-01-18
EP1383508B1 (en) 2006-06-21
EP1383508A4 (en) 2005-07-06
EP2221056A1 (en) 2010-08-25
JP2011168613A (ja) 2011-09-01
WO2002080932A1 (en) 2002-10-17
ATE330615T1 (de) 2006-07-15
ES2266499T3 (es) 2007-03-01
NZ528197A (en) 2007-04-27

Similar Documents

Publication Publication Date Title
CA2719162C (en) Methods of treating acne
WO2003088906A3 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
WO2005046618A3 (en) Methods of treating eczema
AU2002239387A1 (en) Inhibiting gs-fdh to modulate no bioactivity
AU2001251546A1 (en) Method for treating pain by peripheral administration of a neurotoxin
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
CA2406367A1 (en) Method for treating pain by peripheral administration of a neurotoxin
MY150740A (en) Low dose methods for treating disorders in which tnf? activity is detrimental
IL156122A0 (en) Geldanamycin derivative and method of treating cancer using same
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
AU6915396A (en) Multiple sclerosis treatment
AU2003219107A1 (en) Tuberculosis treatment using pleuromutilin derivatives
WO2001028491A3 (en) Method and composition for the treatment of dermatologic diseases
WO2003024391A3 (en) Treatment and prevention of mucositis in cancer patients
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
WO2003099270A8 (en) Methods of treating allergic reactions
WO2003092629A3 (en) Methods of simultaneously treating mucositis and fungal infection
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
AU3743499A (en) Phosphinic acid derivatives
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
EP1465577A4 (en) METHODS FOR ENHANCING THE AESTHETIC ASPECT OF THE SKIN
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
WO2004043228A3 (en) Method of treating sepsis-induced ards

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220405